High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent days and pharmacies warning of “huge problems” with kit deliveries.
The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...
And thankfully, the rapid tests are free for most purposes except travel, where you’ll need to pay for private testing. Some work places will even provide lateral flow tests for free and expect you to ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Coronavirus tests have become increasingly easier to get hold of as the pandemic has progressed. Now more than 163 million Covid-19 tests have been taken in the UK since the start of the pandemic, ...
Free packs of rapid lateral flow tests can be posted to people’s homes or collected at several places across the country. The tests involve rubbing a swab over the tonsils and inside the nose, much ...
A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...
Not long ago, referring to a lateral flow test would have resulted in blank stares, even though they’re common diagnostic devices used in over-the-counter pregnancy tests, for example. But the ...
Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...
The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...
HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...